FTSE 100 movers: Two analysts point out high PE multiple on Hargreaves´ shares
5th Feb 2014 15:07
AB Foods was extending gains for a second session after analysts at Morgan Stanley said on Tuesday that the market was "fundamentally mis-pricing" its Primark retail chain. The company´s shares hit a new record high at 2,930p on the back of those comments. Hargreaves Lansdown´s interim results sh
Read moreGSK's beats on revenues but guidance fails to impress - UPDATE
5th Feb 2014 12:37
GlaxoSmithKline (GSK) saw improved turnover in the fourth quarter as the drugmaker expanded its portfolio and launched new products, but its full year guidance failed to impress. Turnover edged up 2% to £6.9bn in the last three months of 2013, surprising analysts who had expected a turnover of £6.
Read moreLondon pre-open: FTSE to open lower despite US and Asia gains
5th Feb 2014 07:18
City sources predict the FTSE 100 will open 20 points below yesterday's close of 6,449.27, ignoring decent gains seen in both the US and Asia overnight. Upbeat corporate earnings and a bout of bargain hunting helped US markets put in decent gains on Tuesday as stocks recovered from their worst sell
Read moreSunday newspaper round-up: RBS, Centrica, Vodafone
2nd Feb 2014 17:27
The Bank of England will question Royal Bank of Scotland over its capital position in the next two weeks, the Sunday Telegraph reported. The BoE's Prudential Regulatory Authority arm will call in RBS boss Ross McEwan to check on the bank's capital strength in light of his strategy review, due Februa
Read moreGlaxoSmithKline wins positive opinion on diabetes treatment
24th Jan 2014 11:12
Drug maker GlaxoSmithKline said on Friday that the Committee for Medicinal Products for Human Use (CHMP) has recommended marketing authorisation for its albiglutide treatment for type 2 diabetes. The decision by the CHMO, which is part of the European Medicines Agency, was hailed by the company as
Read moreLondon close: FTSE 100 treads water at eight-month high
21st Jan 2014 16:38
- FTSE 100 fails to break 2013 intraday high - Credit squeeze eases in China - IMF lifts global growth forecasts techMARK 2,846.40 -0.25% FTSE 100 6,834.26 -0.04% FTSE 250 16,144.20 -0.51% After a choppy session, UK markets finished broadly flat on Tuesday as the FTSE 100 teetered at levels not re
Read moreGlaxoSmithKline wins approval for new HIV drug
21st Jan 2014 15:23
Drugs maker GlaxoSmithKline rose after reporting that its new HIV treatment, Tivicay, has received approval in Europe. The drug is manufactured by ViiV Healthcare, a company in which GSK, Pfizer and Shionogi are shareholders. Tivicay is for use in combination with other anti-retroviral medicinal
Read moreFTSE 100 movers: Intertek jumps on readacross from SGS
21st Jan 2014 15:09
Intertek, a provider of testing and safety solutions, jumped as a result of readacross from its sector peer, Swiss firm SGS, which posted upbeat full-year results. Consumer products group Unilever was also high riser today after reporting underlying sales growth of 4.3% for 2013, helped by strong
Read moreGSK receives US FDA approval for melanoma treatment Mekinist
9th Jan 2014 07:44
GlaxoSmithKline (GSK) said its melanoma treatment Mekinist has been approved by the US Food and Drug Administration. Mekinist has been approved for use in combination with Tafinlar for the treatment of unresectable or metastatic melanoma with BRAF V600E or V600K mutations. The US regulatory gave
Read moreCable & Wireless Comms incoming Chief acquires 4.3m shares
3rd Jan 2014 16:49
Cable & Wireless Communications on Friday announced that soon-to-be Chief Executive Officer Phil Bentley had purchased 4.3m shares in the international telecoms operator. Bentley, the former Managing Director of British Gas, bought the shares the previous day at 56.912p each for a total spend of £
Read moreLondon close: Stocks surge to two-and-a-half-week high after Fed taper
19th Dec 2013 16:31
- FTSE 100 at highest since December 2nd after Fed taper - Fed scales back stimulus, gives guidance on rates - Carnival jumps late on after FY results - Pharmaceutical and life insurance stocks rise techMARK 2,735.02 +1.40% FTSE 100 6,584.70 +1.43% FTSE 250 15,589.95 +1.45% UK stocks surged to a t
Read moreFTSE 100 movers: Carnival buoyed by Q4 results, drugmakers higher
19th Dec 2013 14:47
Cruise operator Carnival surged into the top spot on the FTSE 100 risers list on Thursday after reporting a smaller-than-expected decline in net revenue yields in the fourth quarter. Net revenue yields in constant dollars fell by 2.1 per cent year-on-year, better than the company's guidance given in
Read moreBroker tips: GlaxoSmithKline, Serco, Britvic
19th Dec 2013 12:23
Jefferies has maintained its 'hold' rating for GlaxoSmithKline (GSK) after Denmark approved the sale of a generic copy of its top-selling inhaled lung drug, Advair. "Sandoz/Vectura's EU branded generic of Advair/Seretide was anticipated, though the timing was uncertain. Confirmation of its approval
Read moreLondon midday: Markets jump one per cent after Fed taper
19th Dec 2013 12:01
- Fed tapers monthly asset purchases by 10bn dollars - Markets rise, Wall Street hits record high - Annual growth of UK retail sales misses estimates techMARK 2,732.70 +1.31% FTSE 100 6,556.63 +0.99% FTSE 250 15,576.80 +1.37% UK markets had held on to their gains by Thursday lunchtime as investors
Read moreBroker snap: Generics threat tightens breathing room at Glaxo, says Jefferies
19th Dec 2013 10:10
Jefferies has maintained its 'hold' rating for GlaxoSmithKline (GSK) after Denmark approved the sale of a generic copy of its top-selling inhaled lung drug, Advair. It was announced on Thursday that Novartis' Sandoz and Vectura have been given the green light by Danish authorities for the V315 AirF
Read more